» Articles » PMID: 22453352

Sacral Neuromodulation for Nonobstructive Urinary Retention: a Meta-analysis

Overview
Date 2012 Mar 29
PMID 22453352
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: : The objective of this study is to systematically review the literature regarding the efficacy of sacral neuromodulation (InterStim) for treatment of nonobstructive urinary retention.

Methods: : Eligible studies were selected through an electronic literature search of PubMed, Cochrane Collaboration, EMBASE, Web of Science and Scopus databases from January 1980 to August 2008. Two investigators independently reviewed all studies to assess methodological quality and inclusion criteria. Eligible studies evaluated sacral neuromodulation using implanted generators with permanent lead placement for treating nonobstructive urinary retention. The primary outcomes assessed were the change in pre- and postoperative postvoid residual and voided volume. Exclusion criteria were neurogenic etiology (ie, spinal cord injury) for urinary retention and non-English studies. The lead authors of all selected studies were contacted to identify ongoing or unpublished research, as was Medtronic, Inc. (Minneapolis, MN). Data were extracted from the selected studies and analyzed using RevMan 5 (Review Manager, Cochrane Collaboration, 2008). The mean difference with a 95% confidence interval was the effect of interest.

Results: : A total of 14 articles met all inclusion criteria for the systematic review. This included one randomized control trial (RCT) and 13 observational studies. Outcome data was available from a total of 7 studies and used in the final analysis. After implantation, the mean difference in postvoid residual decreased 236 mL (95% CI: 219-253, P < 0.00001) and voided volume increased by 299 mL (95% CI: 280-318, P < 0.00001). The randomized control trial alone (n = 51) showed a mean decrease in postvoid residual volume in the implanted group compared with control of 270 mL (95% CI: 180-360, P < 0.00001) and a mean increase in voided volume of 104 mL (95% CI: 55-152, P < 0.0002).

Conclusions: : Based on the available literature, sacral neuromodulation is an effective therapy for treatment of nonobstructive urinary retention.

Citing Articles

Impact of Urethral Sphincter Electrophysiology on Botulinum Toxin A Treatment in Women with Non-Neurogenic Dysfunctional Voiding.

Chang T, Jiang Y, Kuo H Biomedicines. 2024; 12(8).

PMID: 39200367 PMC: 11352200. DOI: 10.3390/biomedicines12081902.


Development of a predictive tool for sacral nerve modulation implantation in the treatment of non-obstructive urinary retention and/or slow urinary stream: a study from the Neuro-Urology Committee of the French Association of Urology.

Nasri J, Al Ashimi I, Tricard T, Fleury R, Matta I, Bey E World J Urol. 2023; 41(11):3075-3082.

PMID: 37783844 DOI: 10.1007/s00345-023-04638-y.


Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey.

Kutukoglu M, Altuntas T, Sahin B, Onur A Turk J Med Sci. 2023; 53(1):206-210.

PMID: 36945940 PMC: 10387836. DOI: 10.55730/1300-0144.5575.


Magnetic soft robotic bladder for assisted urination.

Yang Y, Wang J, Wang L, Wu Q, Ling L, Yang Y Sci Adv. 2022; 8(34):eabq1456.

PMID: 36001667 PMC: 9401625. DOI: 10.1126/sciadv.abq1456.


Dilemmas in Management of the Geriatric Bladder.

Hartigan S, Reynolds W, Smith P Curr Bladder Dysfunct Rep. 2020; 14(4):272-279.

PMID: 33312324 PMC: 7731875. DOI: 10.1007/s11884-019-00541-8.